fibrinogen has been researched along with Ascites in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (55.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, R; Liu, X; Tian, J | 1 |
| Caldin, M; Drigo, M; Piek, CJ; Simioni, P; Zoia, A | 2 |
| Augusto, M; Caldin, M; Drigo, M; Zoia, A | 1 |
| MASETTO, I | 1 |
| HIRATA, T | 1 |
| Dentler, MD; Desai, PB; Einhaus, CM; Jakate, AS; Perrotta, AO; Retzinger, AC; Retzinger, GS | 1 |
| Gollwitzer, R; Graeff, H; Hafter, R; Klaubert, E; Klaubert, W; von Hugo, R | 1 |
| Dudley, FJ; Gibson, PR; Jakobovits, AW; McInnes, IE; Salem, HH | 1 |
| Barnes, T; Halle, P; Hoefs, J | 1 |
| Ansley, JD; Evatt, BL; Fulenwider, JT; McLemore, P; Nordlinger, B; Schwotzer, L; Stein, SF; Wideman, CS | 1 |
| Ansley, JD; Henderson, JM; Kutner, M; Rudman, D; Stein, SF; Wiles, MB | 1 |
| Dvorak, HF; Herzberg, KT; Masse, EM; Meyers, MS; Nagy, JA | 1 |
| Ansley, JD; Fulenwider, JT; Nordlinger, BM; Stein, SF; Warren, WD | 1 |
| Frutiger, S; Hochstrasser, DF; Huber, O; Hughes, GJ; Paquet, N; Tissot, JD; Toussi, A | 1 |
| Gleysteen, JJ; Heckman, MG; Hussey, CV | 1 |
| Cooper, P; Kennedy, HJ; Preston, FE; Triger, DR; Wilde, JT | 1 |
| Boeri, G; Girolami, A; Patrassi, GM; Sartori, MT; Sgarabotto, D; Sturniolo, G | 1 |
| Granack, K; Hamilton, J; Subbarao, V; Ts'ao, C | 1 |
| Lohse, W; Winkler, H; Wolff, H | 1 |
20 other study(ies) available for fibrinogen and Ascites
| Article | Year |
|---|---|
Association of Plasma Fibrinogen Levels on Postoperative Day 1 with 2-Year Survival of Orthotopic Liver Transplantation for HBV-Related HCC.
Topics: Ascites; Carcinoma, Hepatocellular; Fibrinogen; Hepatitis B; Hepatitis B virus; Humans; Liver Neoplasms; Liver Transplantation | 2022 |
Association between ascites and primary hyperfibrinolysis: A cohort study in 210 dogs.
Topics: Animals; Ascites; Blood Coagulation Disorders; Cohort Studies; Dog Diseases; Dogs; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Male; Partial Thromboplastin Time; Prothrombin Time | 2017 |
Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.
Topics: Animals; Ascites; Ascitic Fluid; Blood Coagulation Disorders; Cross-Sectional Studies; Dog Diseases; Dogs; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Male; Partial Thromboplastin Time | 2017 |
Evaluation of hemostatic and fibrinolytic markers in dogs with ascites attributable to right-sided congestive heart failure.
Topics: Animals; Ascites; Biomarkers; Blood Coagulation Disorders; Cardiovascular Agents; Case-Control Studies; Dog Diseases; Dogs; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Male; Partial Thromboplastin Time; Prothrombin Time; Retrospective Studies | 2012 |
[Possibility of differentiation of development of cirrhosis and neoplasms in ascitic fluid through determination of certain blood coagulation factors in ascitic fluid].
Topics: Ascites; Ascitic Fluid; Blood Coagulation Factors; Diagnosis, Differential; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasms; Prothrombin Time | 1958 |
[EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
Topics: Aminocaproates; Aminocaproic Acid; Animals; Ascites; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Coagulants; Deoxyribonuclease I; Enzymes; Fibrinogen; Fibrinolysis; Hemostatics; Mice; Pharmacology; Research; Streptodornase and Streptokinase; Streptokinase; Thrombin | 1963 |
Fibrinogen-coated droplets of olive oil for delivery of docetaxel to a fibrin(ogen)-rich ascites form of a murine mammary tumor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Drug Delivery Systems; Female; Fibrinogen; Infusions, Parenteral; Mammary Neoplasms, Animal; Mice; Olive Oil; Plant Oils; Taxoids | 2004 |
[Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
Topics: Ascites; Ascitic Fluid; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Ovarian Neoplasms | 1983 |
Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
Topics: Adult; Aged; Ascites; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Partial Thromboplastin Time; Peritoneovenous Shunt; Platelet Count; Postoperative Complications; Prospective Studies; Prothrombin Time; Thrombin Time; Vascular Surgical Procedures | 1981 |
Intraperitoneal coagulation in chronic liver disease ascites.
Topics: Ascites; Ascitic Fluid; Blood Coagulation; Blood Proteins; Chronic Disease; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Diseases; Peritoneal Cavity | 1981 |
Accelerated fibrinogen and platelet destruction after peritoneovenous shunting.
Topics: Ascites; Blood Platelets; Cell Survival; Fibrinogen; Hemorrhagic Disorders; Heparin; Humans; Peritoneovenous Shunt; Platelet Count; Vascular Surgical Procedures | 1981 |
Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen.
Topics: Afibrinogenemia; Aged; Ascites; Ascitic Fluid; Blood Proteins; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Peritoneovenous Shunt; Plasminogen | 1980 |
Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity.
Topics: Animals; Ascites; Capillary Permeability; Female; Fibrin; Fibrinogen; Iodine Radioisotopes; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Muscle, Skeletal; Ovarian Neoplasms; Peritoneal Cavity; Peritoneum | 1995 |
Effect of reinfusion of ascitic fluid with the LeVeen shunt on fibrinogen and platelet survival.
Topics: Ascites; Ascitic Fluid; Blood Platelets; Cell Survival; Fibrinogen; Hemorrhagic Disorders; Humans; Peritoneovenous Shunt; Prospective Studies | 1978 |
Polypeptide marker and disease patterns found while mapping proteins in ascitis.
Topics: Acute Disease; alpha 1-Antitrypsin; Ascites; Biomarkers; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Haptoglobins; Humans; Pancreatitis; Peptide Mapping; Peptides | 1992 |
The cause of coagulopathy after peritoneovenous shunt for malignant ascites.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Blood Coagulation Disorders; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Neoplasms; Partial Thromboplastin Time; Peritoneovenous Shunt; Platelet Count; Prothrombin Time | 1990 |
Coagulation disturbances following ascites recirculation.
Topics: Ascites; Ascitic Fluid; Blood Coagulation Disorders; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infusions, Intravenous; Partial Thromboplastin Time; Platelet Count; Prothrombin Time | 1990 |
A DIC-like picture on plasma and ascitic fluid of cirrhotic patients.
Topics: Aged; Ascites; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen; Prothrombin Time; Reference Values; Tissue Plasminogen Activator | 1988 |
Platelet interaction with a pancreatic ascites tumor.
Topics: Animals; Antithrombin III; Apyrase; Ascites; Aspirin; Blood Coagulation; Blood Platelets; Cricetinae; Epoprostenol; Fibrinogen; Humans; Mesocricetus; Microscopy, Electron; Pancreatic Neoplasms; Platelet Aggregation; Platelet Count; Serotonin; Thromboxane B2 | 1986 |
[Significance of antithrombin III in clinical liver transplantations].
Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Ascites; Child; Child, Preschool; Female; Fibrinogen; Follow-Up Studies; Humans; Infant; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Proteinuria; Thrombosis | 1985 |